Thus, our data hint at the possibility of modulating caspase-10 expression as a therapeutic oncological target; repression of caspase-10 reduces cytokine expression (Figure 6) and favors apoptosis (Figure 1), potentially resulting in impaired tumor growth. Here, CASP10 is linked to neoplasm.